Condition
Eyes Dry Chronic
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Completed3
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07413172Phase 2Not Yet Recruiting
Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
NCT07266948Phase 4Recruiting
Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work
NCT05461469CompletedPrimary
CDL Validation Study
NCT06278584Not ApplicableCompleted
iLux Treatment for Meibomian Gland Dysfunction
NCT01338610Phase 2CompletedPrimary
ESBA105 in Patients With Severe Dry Eye
Showing all 5 trials